PIK3CA and meningioma: Alpelisib, also known as BYL719, is a selective inhibitor of the constitutively activated PI3Kα product of PIK3CA in response to either of two hot spot mutations: p.His1047Arg or p.Glu545Lys, both of which present in few meningiomas.